Prescribing and Rationality of Diabetes Therapy
Kata Kunci:
Type 2 Diabetes Mellitus, Antidiabetic Drugs, Prescribing PatternsAbstrak
Diabetes mellitus is a metabolic disorder characterized by elevated blood glucose due to impaired insulin secretion or action. This study aimed to analyze prescribing patterns and evaluate the rationality of antidiabetic therapy in hospitalized patients with type 2 diabetes mellitus at Arifin Achmad Regional General Hospital, Pekanbaru, during 2021–2023. A retrospective cross-sectional study was conducted using 76 eligible medical records. Most patients were female (57%) and aged 45–54 years. Insulin monotherapy, particularly novorapid, was the most commonly prescribed treatment, followed by metformin and combination insulin therapy. Rationality assessment showed that most prescriptions met criteria for appropriate indication, drug selection, dosage, patient suitability, and dosing interval. However, potential drug interactions were identified, mainly of moderate severity. In conclusion, prescribing patterns were generally rational, although monitoring of potential drug interactions remains necessary to ensure safe and effective therapy.
Referensi
Wells BG, Dipiro JT, Dipiro CV, Schwinghammer TL. (2009). Pharmacotherapy Handbook (Vol. 7).
International Diabetes Federation. 2021. IDF Diabetes Atlas 10th edition. IDF 2021. http://diabetesatlas.org (diakses pada tanggal 26 Agustus 2022)
Pelawi, N. G., & Fauzia, D. (2022). Pola penggunaan obat antidiabetik oralpada pasien diabetes melitus tipe 2 di Puskesmas Tenayan Raya Kota Pekan Baru. Jurnal Kedokteran Syiah Kuala, 22(4), 207–212.
Hongdiyanto, A., Yamlean, P. V. Y., & Supriati, S. (2014). Evaluasi Kerasionalan Pengobatan Diabetes Melitus Tipe 2 Pada Pasien Rawat Inap Di Rsup Prof. Dr. R. D. Kandou Manado Tahun 2013. Pharmacon Jurnal Ilmiah Farmasi – UNSRAT Vol., 3(2), 77–87
PERKENI. (2021). Pedoman Petunjuk Praktis Terapi Insulin Pada Pasien Diabetes Mellitus 2021. Pb Perkeni, 1–70.
Rita, nova. (2018). Hubungan Jenis Kelamin, Olah Raga Dan Obesitas Dengan Kejadian Diabetes Mellitus Pada Lansia. Jik- Jurnal Ilmu Kesehatan, 2(1), 93–100. https://doi.org/10.33757/jik.v2i1.52
Pokhrel, S. (2024). No TitleΕΛΕΝΗ. Αγαη, 15(1), 37–48.
Anggraeni, F., Putri, N. A., Septiani, R. A., Indriyani, W., & Sulvita, W. (2023). Novel Drug Delivery System (NDDS) Diabetes Mellitus Berdasarkan Pemberian Rute Obat Secara Intramuskular. Jurnal Pendidikan Dan Konseling, 5, 2023–2025
Fahmi, K. N., & Urfiyya, Q. A. (2022). Gambaran Penggunaan Insulin Pada Pasien Diabetes Melitus Tipe 2 Di RSI Hidayatullah Yogyakarta. Jurnal Inovasi Farmasi Indonesia, 4(1), 12–21
Lina, R. N., & Nuringtyas, A. R. (2023). Evaluasi Peresepan Obat Antidiabetik Oral Tipe II dengan Penyakit Penyerta Pada Pasien BPJS Rawat Jalan di RSUD RAA Soewondo Pati. Cendekia Journal of Pharmacy, 7(2), 165–175.
Yuliana, D. (2024). Literature Review : Studi Rasionalitas Penggunaan Obat Antidibetes Pada Penyakit Diabetes Melitus Tipe 2 Yang Mengalami Komplikasi Nefropati. Makassar Pharmaceutical Science Journal, 2024(2), 2024–2156.
Kemenkes RI. (2011). M odul. 1–23.
Kurnianta, P. D. M., Soares, G. I. B., Prasetya, A. A. N. P. R., & Yuliawati, A. N. (2022). Evaluasi Rasionalitas Penggunaan Antidiabetes Oral pada Pasien Diabetes Melitus Tipe 2 Rawat Inap di Rumah Sakit Nasional di Dili. Jurnal Farmasi Indonesia, 19(1), 148–160. https://doi.org/10.31001/jfi.v19i1.1338
Rahayuningsih, N. (2017). Evaluasi Kerasionalan Pengobatan Diabetes Melitus tipe 2 pada pasien rawat inap di RSUD dr. Soekardjo Tasikmalaya. Jurnal Kesehatan Bakti Tunas Husada: Jurnal Ilmu-Ilmu Keperawatan, Analis Kesehatan Dan Farmasi, 17(1), 183. https://doi.org/10.36465/jkbth.v17i1.205
Jabbar, A., Yusuf, M. I., Pascayantri, A., & Nurwati, A. (2024). Rationality of Antidiabetic Use for Type-II Diabetes Mellitus Patients at Kendari City Hospital Rasionalitas Penggunaan Antidiabetik Pasien Diabetes Melitus Tipe II di RSUD Kota Kendari. 6(2).
Anggraini, D. (2022). Aspek linis Dan Pemeriksaan Laboratorium Penyakit Ginjal Kronik. An-Nadaa Jurnal Kesehatan Masyarakat, 9(2), 236.
Listiani, putu ayu ratih (2015). Potensi interaksi obat antidiabetic pada pasien diabetes melitus tipe. Dm,6.
Feinstein, J., Dai, D., Zhong, W., Freedman, J., & Feudtner, C. (2015). Potential drug-drug interactions in infant, child, and adolescent patients in Children’s Hospitals. Pediatrics, 135(1), e99–e108. https://doi.org/10.1542/peds.2014-2015
Rahmawaty, A., & Hidayah, P. H. (2020). Hubungan Drug Related Problems (DRPs) Kategori Interaksi Obat pada Penggunaan Obat Pasien Diabetes Mellitus Tipe 2. Cendekia Journal of Pharmacy, 4(1), 80–88. https://doi.org/10.31596/cjp.v4i1.76
Unduhan
Terbitan
Bagian
Lisensi
Hak Cipta (c) 2026 Adrian Mulya, Denia Pratiwi, Isna Wardaniati, Junisa Prahestina
Artikel ini berlisensiCreative Commons Attribution-ShareAlike 4.0 International License.
